
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes

Thursday Nov 17, 2022
MDT and patient perspectives on risk factors for stroke in T2D
Thursday Nov 17, 2022
Thursday Nov 17, 2022
touchMDT for touchNEUROLOGY
Listen to key experts from a multidisciplinary team, plus a patient with T2D who has survived a stroke, discuss the risk factors for stroke in patients with T2D and its impact upon daily life
The multidisciplinary team
- Consultant endocrinologist: Prof. Tina Vilsbøll, Copenhagen, Denmark
- Primary care physician: Dr Yassir Javaid, Northamptonshire, UK
- Patient: Ms Hyvelle Ferguson-Davis, Florida, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurology.com/cme/mdt-role-glp1ras-in-modern-management-stroke-in-patients-with-t2d/

Thursday Nov 17, 2022
MDT and patient perspectives on risk factors for stroke in T2D
Thursday Nov 17, 2022
Thursday Nov 17, 2022
touchMDT for touchENDOCRINOLOGY
Listen to key experts from a multidisciplinary team, plus a patient with T2D who has survived a stroke, discuss the risk factors for stroke in patients with T2D and its impact upon daily life
The multidisciplinary team
- Consultant endocrinologist: Prof. Tina Vilsbøll, Copenhagen, Denmark
- Primary care physician: Dr Yassir Javaid, Northamptonshire, UK
- Patient: Ms Hyvelle Ferguson-Davis, Florida, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/mdt-role-glp1ras-in-modern-management-stroke-in-patients-with-t2d

Thursday Nov 17, 2022
MDT perspectives on how GLP-1 RAs can reduce stroke risk
Thursday Nov 17, 2022
Thursday Nov 17, 2022
touchMDT for touchNEUROLOGY
Listen to key experts from a multidisciplinary team discuss how GLP-1 RAs can help to reduce the incidence of stroke in patients with T2D
The multidisciplinary team
- Primary care physician: Dr Yassir Javaid, Northamptonshire, UK
- Consultant endocrinologist: Prof. Tina Vilsbøll, Copenhagen, Denmark
- Consultant neurologist: Prof. Georgios Tsivgoulis, Athens, Greece
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurology.com/cme/mdt-role-glp1ras-in-modern-management-stroke-in-patients-with-t2d/

Thursday Nov 17, 2022
MDT perspectives on how GLP-1 RAs can reduce stroke risk
Thursday Nov 17, 2022
Thursday Nov 17, 2022
touchMDT for touchENDOCRINOLOGY
Listen to key experts from a multidisciplinary team discuss how GLP-1 RAs can help to reduce the incidence of stroke in patients with T2D
The multidisciplinary team
- Primary care physician: Dr Yassir Javaid, Northamptonshire, UK
- Consultant endocrinologist: Prof. Tina Vilsbøll, Copenhagen, Denmark
- Consultant neurologist: Prof. Georgios Tsivgoulis, Athens, Greece
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/mdt-role-glp1ras-in-modern-management-stroke-in-patients-with-t2d

Tuesday Nov 15, 2022
Tuesday Nov 15, 2022
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading experts discuss the clinical relevance of the immunogenicity of immune checkpoint inhibitors for the treatment of cancer, informed by experience in inflammatory diseases.
The experts:
Prof. Peter Galle, University of Mainz, Germany,
Dr Victor Moreno, START Madrid-FJD, Hospital Fundación Jiménez Díaz, Madrid, Spain,
Dr Vibeke Strand, Stanford University School of Medicine, Palo Alto, CA, USA.
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/immune-checkpoint-inhibitors-immunogenicity/

Monday Nov 14, 2022
MDT perspectives on managing patients with complement inhibitors
Monday Nov 14, 2022
Monday Nov 14, 2022
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team explore the use of complement inhibitors for patients with PNH.
The multidisciplinary team
- Primary care physician: Dr Will Evans, UK
- Haematologist: Professor Régis Peffault de Latour, France
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novartis. This medical education is provided by touchIME.
For further information visit: touchONCOLOGY

Monday Nov 14, 2022
MDT and patient perspectives on recognizing and referring patients with PNH
Monday Nov 14, 2022
Monday Nov 14, 2022
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team, and a patient with PNH, discuss the signs and symptoms of PNH and how these inform the clinical diagnosis.
The multidisciplinary team
- Primary care physician: Dr Will Evans, UK
- Haematologist: Professor Régis Peffault de Latour, France
- Patient: Ms Jess Ratcliffe, UK
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novartis. This medical education is provided by touchIME.
For further information visit: touchONCOLOGY

Monday Nov 14, 2022
MDT and patient perspectives on the patient journey in PNH
Monday Nov 14, 2022
Monday Nov 14, 2022
touchMDT for touchONCOLOGY
Listen to a haematologist and a patient with PNH discuss the experience of living with PNH from a patient’s perspective.
The multidisciplinary team
- Haematologist: Professor Régis Peffault de Latour, France
- Patient: Ms. Jess Ratcliffe, UK
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novartis. This medical education is provided by touchIME.
For further information visit: touchONCOLOGY

Thursday Nov 03, 2022
Thursday Nov 03, 2022
touchIN CONVERSATION for touchONCOLOGY
Listen to two chronic myeloid leukaemia experts, Prof. Simona Soverini and Dr Daniela Žáčková discuss the mechanisms of action and latest data for new and emerging treatment options for patients with chronic myeloid leukaemia after two prior lines of therapy, and how they might impact the management of chronic myeloid leukaemia. The discussion is guided by pre-canvassed questions from the chronic myeloid leukaemia clinical community.
This touchPODCAST is intended for non-UK and non-US HCPs only.
This activity is funded by an unrestricted independent medical education grant from Novartis and is provided by touchIME.
For further information visit our website: touchONCOLOGY

Tuesday Oct 25, 2022
MDT and patient perspectives on the diagnostic tools for non-CF bronchiectasis
Tuesday Oct 25, 2022
Tuesday Oct 25, 2022
touchMDT for touchINFECTIOUS DISEASES
Listen to key experts from a multidisciplinary team, and a patient, review the diagnostic tools for non-CF bronchiectasis.
The multidisciplinary team
- Primary care physician: Professor Barbara Yawn, USA
- Pulmonologist: Professor James Chalmers, Scotland
- Radiologist: Professor Mary Salvatore, USA
- Patient: Marta Almagro, Spain
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Insmed. This medical education is jointly provided by USF Health and touchIME.
For further information visit: touchINFECTIOUS DISEASES